We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+17.66%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$139M
AUM Growth
-$36.7M
Cap. Flow
-$54M
Cap. Flow %
-38.93%
Top 10 Hldgs %
19.06%
Holding
117
New
26
Increased
16
Reduced
43
Closed
32

Top Buys

Rank Stock Value
1
LAD icon
Lithia Motors
LAD
+$2.3M
2
RGEN icon
Repligen
RGEN
+$1.87M
3
GIMO
Gigamon Inc.
GIMO
+$1.82M
4
ATRC icon
AtriCure
ATRC
+$1.75M
5
AMN icon
AMN Healthcare
AMN
+$1.73M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Healthcare 24.99%
3 Consumer Discretionary 16.14%
4 Financials 9.24%
5 Industrials 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUDA
26
DELISTED
Barracuda Networks, Inc.
CUDA
$2.06M 1.48%
51,910
-13,000
-20% -$534K
GIMO
27
DELISTED
Gigamon Inc.
GIMO
$2.03M 1.46%
+61,535
New +$1.82M
AMAG
28
DELISTED
AMAG Pharmaceuticals
AMAG
$2.02M 1.46%
29,325
-10,840
-27% -$682K
MPWR icon
29
Monolithic Power Systems
MPWR
$64.7B
$2M 1.44%
39,470
+135
+0.3% +$7.14K
TREE icon
30
LendingTree
TREE
$445M
$1.95M 1.41%
24,845
-30,795
-55% -$1.9M
ATRC icon
31
AtriCure
ATRC
$2.04B
$1.93M 1.39%
+78,455
New +$1.75M
PAYC icon
32
Paycom
PAYC
$7.53B
$1.9M 1.37%
55,510
-6,950
-11% -$240K
PN
33
DELISTED
Patriot National, Inc.
PN
$1.89M 1.36%
118,130
-23,570
-17% -$359K
MOH icon
34
Molina Healthcare
MOH
$10.2B
$1.87M 1.35%
26,654
-9,450
-26% -$632K
ACAD icon
35
Acadia Pharmaceuticals
ACAD
$4.55B
$1.86M 1.34%
44,476
-16,642
-27% -$644K
NTUS
36
DELISTED
Natus Medical Inc
NTUS
$1.86M 1.34%
43,604
-15,675
-26% -$625K
WCIC
37
DELISTED
WCI Communities, Inc.
WCIC
$1.85M 1.33%
75,790
+10,900
+17% +$260K
PNFP icon
38
Pinnacle Financial Partners Inc
PNFP
$15.8B
$1.82M 1.31%
+33,405
New +$1.65M
AAC
39
DELISTED
AAC Holdings
AAC
$1.81M 1.3%
41,470
-5,170
-11% -$190K
INGN icon
40
Inogen
INGN
$174M
$1.78M 1.29%
+39,970
New +$1.53M
DXCM icon
41
DexCom
DXCM
$28.8B
$1.77M 1.28%
88,720
-31,364
-26% -$551K
ADPT
42
DELISTED
Adeptus Health Inc
ADPT
$1.77M 1.28%
18,635
-6,330
-25% -$436K
ACHC icon
43
Acadia Healthcare
ACHC
$2.62B
$1.71M 1.23%
21,850
-7,990
-27% -$575K
NBIX icon
44
Neurocrine Biosciences
NBIX
$18.7B
$1.71M 1.23%
35,735
+18,325
+105% +$777K
STL
45
DELISTED
Sterling Bancorp
STL
$1.59M 1.15%
108,305
+6,650
+7% +$90.5K
HUBS icon
46
HubSpot
HUBS
$11.9B
$1.58M 1.14%
31,895
+9,100
+40% +$418K
MDXG icon
47
MiMedx Group
MDXG
$622M
$1.54M 1.11%
132,885
+12,445
+10% +$128K
THOR
48
DELISTED
THORATEC CORPORATION
THOR
$1.46M 1.05%
+32,770
New +$1.43M
MINI
49
DELISTED
Mobile Mini Inc
MINI
$1.45M 1.04%
34,395
+3,285
+11% +$135K
BURL icon
50
Burlington
BURL
$23.4B
$1.44M 1.04%
28,057
-14,280
-34% -$763K

Similar funds

Lisanti Capital Growth's Q2 2015 Portfolio in Review

As of Q2 2015, Lisanti Capital Growth held 117 positions worth $139M, down 21% from $175M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $54M in Q2 2015, closing 32 positions and reducing 43 holdings. Its most notable exit was Qualys, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lisanti Capital Growth opened a new position in Lithia Motors worth $2.44M.

  • Lisanti Capital Growth's largest Q2 2015 buy was Lithia Motors: 21,595 shares worth $2.44M.
  • Lisanti Capital Growth added most to Neurocrine Biosciences in Q2 2015, an estimated $777K increase.
  • Lisanti Capital Growth's biggest Q2 2015 reduction was XPO, cutting an estimated $2.49M.
  • Lisanti Capital Growth fully exited Qualys in Q2 2015, selling an estimated $3.57M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $139M portfolio in Q2 2015.
  • Lisanti Capital Growth opened 26 new positions and closed 32 in Q2 2015.
  • Lisanti Capital Growth's portfolio value fell 21% quarter-over-quarter to $139M.

Based on Lisanti Capital Growth's 13F filing for Q2 2015, filed 24 Jul 2015.